Simultaneous analysis of cytokines and co‐stimulatory molecules concentrations by ELISA technique andof probabilities of measurable concentrations of interleukins IL‐2, IL‐4, IL‐5, IL‐6, CXCL8 (IL‐8), IL‐10, IL‐13 occurring in plasma of healthy blood donors
Authors:
Open Access
- 1 January 2006
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 65237
Abstract
Background. The cytokine network remarkably influences homeostasis. There is not a complex analysis describing physiological values of soluble cytokines in healthy individuals. Methods. Authors used the ELISA method to detect soluble cytokines and costimulatory molecules simultaneously in the plasma of 30 blood donors. Results. Data are shown as (a range of concentrations; median) IL‐2 (0–74.48 pg/mL; 0), IL‐4 (0–65.18 pg/mL; 0), IL‐5 (0–86.69 pg/mL; 0), IL‐6 (0–73.17 pg/mL; 0), IL‐8 (0–74.8 pg/mL; 0), IL‐10 (0–12.6 pg/mL; 0), IL‐13 (0–3.9 pg/mL; 0), sCD40L (0–3.5 ng/mL; 0), and TNF‐α (0–67.6; 0). For the IL‐6 receptor, the concentration was 75.89 ± 35.83 ng/mL (average ± SD), sCD23 28.9 ± 15.22 ng/mL, and TGFβ1 14.98 ± 12.39 ng/mL. A special approach was taken for the analysis of values, which had median 0. A model for the probability of detectable level′s occurrence for each interleukin was formulated with intervals of confidence. Conclusion. These results provide reference values for cytokine levels in the plasma of healthy individuals.Keywords
Funding Information
- Interní grantová agentura Ministerstva zdravotnictví (NR8003-3/2004)
This publication has 28 references indexed in Scilit:
- Infliximab use in Crohn’s diseaseExpert Opinion on Biological Therapy, 2005
- IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantationBlood, 2004
- Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromesJournal of Allergy and Clinical Immunology, 2004
- IL-13 Effector FunctionsAnnual Review of Immunology, 2003
- Prognostic value of plasma interleukin‐6 levels in patients with chronic lymphocytic leukemiaCancer, 2002
- The Role of Soluble CD23 in Distinguishing Stable and Progressive Forms of B-chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2002
- Circulating IL‐6‐type cytokines and sIL‐6R in patients with multiple myelomaBritish Journal of Haematology, 1999
- Dysregulation of Cytokines During Graft-Versus-Host DiseaseJournal of Hematotherapy, 1996
- Elevation of circulating IL‐6 in patients with acute non‐lymphocytic leukemiaEuropean Journal of Haematology, 1994
- Increased serum interleukin 6 levels in patients with myelodysplastic syndromesLeukemia Research, 1992